RIPERTAMAB
Clinical trials for RIPERTAMAB explained in plain language.
Never miss a new study
Get alerted when new RIPERTAMAB trials appear
Sign up with your email to follow new studies for RIPERTAMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to tame rare nerve disease
Disease control Not yet recruitingThis trial tests a drug called ripertamab in people with neuromyelitis optica spectrum disorder (NMOSD), a rare condition where the immune system attacks the optic nerves and spinal cord. Participants receive the drug by IV infusion four times over 73 weeks and are monitored for …
Matched conditions: RIPERTAMAB
Phase: PHASE1, PHASE2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug may help kids with kidney disease avoid relapses
Disease control Not yet recruitingThis study tests whether one or two doses of ripertamab can help children aged 16 and older who have frequent relapses or steroid-dependent nephrotic syndrome. The goal is to see which dose works better at preventing relapses and reducing the need for steroids. The trial will enr…
Matched conditions: RIPERTAMAB
Phase: NA • Sponsor: Mao Jianhua • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC